期刊文献+

IgA肾病进展中MMP-2、TIMP-2与VEGF的表达变化 被引量:7

Study on the expression of VEGF,MMP-2 and TIMP-2 in the progression of IgA nephropathy
下载PDF
导出
摘要 目的探索在IgA肾病进展过程中MMP-2、TIMP-2与VEGF的表达变化、相互关系及其对逐渐进展的肾纤维化的影响。方法收集60例确诊为IgA肾病的肾穿刺活检标本,将其分为5级,随机选取10例同期的肾小球微小病变作为对照组。利用免疫组化技术和图像分析技术检测病例组与对照组中MMP-2、TIMP-2、VEGF的表达。结果随着IgA肾病进展,MMP-2和VEGF表达均在早期出现表达增强,随病变发展逐渐下降,TIMP-2表达强度则逐渐增加,MMP-2/TIMP-2的比值亦在短暂上升后出现下降。MMP-2与TIMP-2呈负相关关系,与VEGF呈正相关关系。结论MMP-2/TIMP-2系统及VEGF的表达变化对于IgA肾病的进展具有重要影响,MMP-2/TIMP-2自然平衡的破坏对于肾纤维化过程具有关键性作用。 Purpose The present study is undertaken to detect effect of MMP-2,TIMP-2 and VEGF in the progression of IgA Nephropathy and to identify any possible links between them.Methods Included in this study were 60 samples from patients with IgA Nephropathy.Select randomly 10 biopsy-samples of minimal-change nephtotic syndrome in same period as comparison.To detected the expression of MMP-2,TIMP-2 and VEGF by immunohistochemistry and image analysis.Results The ratio of MMP-2/TIMP-2 and expression of MMP-2 and VEGF in IgAN increased shortly at earlier stage,then decreased gradually.Expression of TIMP-2 in IgAN enhanced gradually with the progression of IgAN.MMP-2 and TIMP-2 assumed negative correlativity;MMP-2 and VEGF assumed positive correlativity.Conclusions The changes of the expression of MMP-2/TIMP-2 and VEGF may take part in the progression of IgA nephropathy.The damage of nature balance between MMP-2 and TIMP-2 may play an important role in the progression of renal fibrosis.
作者 傅思莹 陶瑜
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2008年第5期573-576,共4页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献15

  • 1D'Amico G. Natural history of idiopathic IgA nephropathy and factots predictive of disease outcome [ J ]. Semin Nephrol, 2004,24(3) :179 - 196.
  • 2蒋镭,吕继成,陈文芳,王素霞,邹万忠,刘刚,张宏,王海燕.IgA肾病简明半定量病理评分方法及其与预后的关系[J].中华肾脏病杂志,2007,23(5):278-282. 被引量:40
  • 3Mclennan S V,Martell S K,Yue D K. Effects of mesangium glycation on matrix metallo-proteinase activities:possible role in diabetic nepbropatby [ J ]. Diabetes,2002,51 ( 8 ) :2612 - 2618.
  • 4Mclennan S V, Kelly D J, Cox A J, et al. Decreased matrix degradation in diabetic nephropathy : effects of ACE inhibition on the expression and activities of matrix metalloproteinases [ J ]. Diabetologia,2002,45(2) :268 -275.
  • 5Akiyama K, Shikata K, Sugimoto H, et al. Changes in serum con-centrations of matrix metallo-proteinases, tissue inhibitors of metalloproteinases and type Ⅳ collagen in patients with various types of glomerulonephritis[ J]. Res Commun Mol Pathol Pharmacol,1997, 95(1) :115 -128.
  • 6王俊,郭继华,孟伟,师龙生,陈朝轮.移植肾组织TGF-β_1和MMP-2表达及IV型胶原沉积与慢性移植肾肾病的关系[J].中华器官移植杂志,2006,27(8):478-480. 被引量:7
  • 7郭继华,王俊,孟伟,师龙生,张和平.慢性异体肾移植病人肾纤维化组织中MMP-2、TIMP-1、Vimentin、Keratin免疫组化定量分析[J].新疆医科大学学报,2006,29(9):815-817. 被引量:5
  • 8庄永泽,陈香美,师锁柱,吴镝,张燕平,田月.IgA肾病患者纤溶酶原激活物的变化及临床意义[J].临床与实验病理学杂志,2002,18(5):506-508. 被引量:20
  • 9McLennan S V,Martell S Y,Yue D K. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells:possible role in mesangium accumulation [ J ]. Diabetologia,2000,43 ( 5 ) :642 - 648.
  • 10Matsummoto K, Kanmatsuse K. Elevated vascular endothelial growth facor levels in the urine of patients with minimal-change nephrotic syndrome [ J ]. Clin Nephrol,2001 , 55 (4) :269 - 274.

二级参考文献44

  • 1姚丽娜,李红,刘章锁.结缔组织生长因子与肾纤维化的研究进展[J].国外医学(移植与血液净化分册),2005,3(1):16-20. 被引量:8
  • 2王平贤,肖亚,张艮甫,冯嘉瑜,方针强,范明齐,黄赤兵.减少神经钙蛋白阻滞剂用量对CAN肾功能的影响[J].医学临床研究,2004,21(7):709-711. 被引量:6
  • 3李光韬,张宏,吕继成,蒋镭,陈育青,邹万忠,王海燕.合并毛细血管襻纤维素样坏死的原发性IgA肾病患者的预后[J].中华肾脏病杂志,2006,22(1):5-8. 被引量:9
  • 4叶任高 沈清瑞.肾脏病诊断和治疗学[M].北京:人民卫生出版社,1994.276-277.
  • 5[1]Vassalli JD,Sappino AP,Belin D.The plasminogen activator/plasmin system.J Clin Invest,1991;88:1067~72
  • 6[2]Xu Y,Hagege J,Mougenot B et al.Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney.Kidney Int,1996;50:2011~9
  • 7[3]Yamamoto K,Loskutoff DJ,Saitor H.Renal expression of fibrinolytic genes and tissue factor in a murine model of renal disease as a function of age.Semin Thromb Heamost,1998;24(3):261~8
  • 8[4]Aya N,Yoshioka K,Murakami K et al.Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis.J Pathol,1992;166(3):289~95
  • 9[5]Colucci M, Semeraro N, Montemurro P et al.Urinary procoagulant and fibrinolytic activity in human glomerulonephri-tis.Relationship with renal function.Kidney Int,1991;39:1213~7
  • 10[7]叶应妩,李健斋,王玉琛主编. 临床实验诊断学(上册).北京:人民出版社,1988:1159~64

共引文献92

同被引文献44

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部